Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Abbott

It cost $38,398 for a single shot of a very old cancer drug

Lupron, a drug patented half a century ago, treats advanced prostate cancer. It costs a few hundred dollars in the U.K. — so why are U.S. hospitals charging so much more to administer it?

WEKU

Abbott plans a new $500M baby-formula plant to increase U.S. capacity for the vital product

Abbott Laboratories is building a new infant-formula manufacturing plant after the product shortage of the past year revealed gaps in U.S. production capacity.

Tribune News Service

Similac baby formula products recalled

The recall, issued on Oct. 14, includes the brands Similac and Pedialyte Electrolyte Solution

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

Special Olympics athlete Josh Holley is one step closer to conquering Abbott World Marathon Majors

Holley’s mission is to bring awareness to all disabilities with the message, “Our Ability is STRONGER than our dis-Ability.”

Chicago Sun-Times

Abbott recalls select baby formula over spoilage concerns

Select Similac products are part of a new recall from Abbott Nutrition.

Axios

Baby formula disaster failed to dent Abbott Labs’ ESG score

Several months after the US government began investigating an Abbott Laboratories baby-formula plant for its connection to the deaths of at least two infants, the world’s most influential judge of corporate environmental, social and governance practices upgraded the company.

Tribune News Service

Sheryl Lee Ralph on Abbott Elementary, being ‘black famous’ and scolding Kimmel

The 65-year-old mega-talent has been criminally underappreciated until now – ‘Isn’t it such a blessing that I could remain relevant after all of these years?’

The Guardian - US

Read news from The Economist, FT, and more,
with one subscription

Here's what the FDA says contributed to the baby formula shortage crisis

The Food and Drug Administration rattled off 15 reasons behind the national baby formula shortage, but couldn't identify a specific person or agency responsible.

WEKU

FDA concedes delays in response to baby formula shortage

U.S. health regulators say their response to the ongoing infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory

The Independent UK

Neal Justin: 'Abbott Elementary' is back in session

"The White Lotus" may have taken the most Emmys this year but "Abbott Elementary" star Sheryl Lee Ralph went home with our hearts.

Tribune News Service

Who is Emmy winner Quinta Brunson ... besides the woman who had to step over Kimmel?

Brunson had already made history when she was nominated for three Emmys for Abbott Elementary

WEKU

Ken Paxton again tries to intervene in suit with Dallas hospital over transgender care

DALLAS — Texas Attorney General Ken Paxton is attempting for the second time to intervene in a legal fight over gender-affirming medical care at two Dallas hospitals.

Tribune News Service

Latest recalls of formula meant frantic search for family of suburban boy, 5, who needs it to survive

With help from La Rabida Children’s Hospital, Zayne Negoski of Joliet got an alternative tube-feeding formula. But his family and those of other medically needy kids have struggled and often had to pay more after Aug. 10 recall.

Chicago Sun-Times

PHILADELPHIA — The world is about to see a whole lot more from Abbott Elementary star and creator Quinta Brunson.

The Philadelphia Inquirer

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Is Abbott Labs A "Strong Buy" After Earnings?

Leading healthcare company Abbott Laboratories (ABT) reported strong second-quarter results. And given the company is well-positioned to capitalize on its diverse business and recent FDA approvals, is it wise to buy the stock now? Let’s find out.

Chicago Tribune

Abbott reports strong earnings despite infant formula crisis

Abbott Laboratories reported strong earnings Wednesday, despite spending recent months responding to criticism over problems that led to the shutdown of one of its infant formula-producing plants.

StockNews.com

2 Medical Stocks That Are Attractive Buys Right Now

Amid an inflationary environment, the medical sector is poised to stay afloat given the inelastic demand for medical products and services, impressive breakthroughs, and the rising need to serve an aging population. Therefore, fundamentally sound medical stocks Abbott Laboratories (ABT) and Utah Medical Products (UTMD) could be solid investments right…

StockNews.com

Is Abbott Stock a Buy at $105 as Production in Troubled Plant Resumes?

Leading healthcare company Abbott Laboratories (ABT) reported robust first-quarter results. And the company is well-positioned to benefit from its diversified business. Moreover, as ABT is resuming infant formula production at its Michigan facility, is the stock a good buy at the current price level? Read more to find out….

Get all your
news in one place.

100’s of premium titles.
One news app.

Mic

Quinta Brunson had the perfect response to Jimmy Kimmel's dumb Emmys bit

"I'm going to be on his show on Wednesday, so I might punch him in the face. I don't know, we’ll see what happens.”

WEKU

Abbott reopens Michigan baby formula plant after flooding

Abbott's facility has now closed and reopened twice this year. The baby formula plant had previously closed in February because of bacterial contamination.

The Guardian - US

Hopes US baby formula shortage could ease as key Abbott plant restarts

Factory in Sturgis, Michigan shut down in May after storms that produced torrential flooding

The Independent UK

Production resumes at troubled Abbott baby formula factory

Abbot Nutrition says baby formula production has resumed at the Michigan plant whose February shutdown over contamination contributed to a national shortage

StockNews.com

This Biotech Stock Looks Like a Prime Growth Play

Diversified healthcare company Abbott (ABT) has demonstrated significant innovations across its segments, and given its dominant market position, the company’s prospects look bright. The stock could be a solid choice as it is well-positioned to survive short-term market fluctuations. Let’s discuss this in detail….

StockNews.com

This Top-Rated Healthcare Stock Is Trading at a 25% Discount

Medical device company Abbott Laboratories (ABT) reported impressive first-quarter results and affirmed its strong performance guidance for fiscal 2022. Furthermore, the company is well-positioned to benefit from its diversified business. However, amid the heightened market volatility, the stock is trading 25.5% below its 52-week high. So, the current dip in…

Benzinga

FDA Probes Another Infant Death Given Abbott Formula, Less Than Month After Troubled Plant Reopens

Problems for Abbott Laboratories' (NYSE: ABT) Sturgis plant in Michigan for baby formula powder refuse to subside. The FDA was recently notified of another infant's death who was given formula made at Abbott's Sturgis facility.

1 … 6 7 8 9

People

Mangeet Kaur BounsMangeet

595 stories

Tyler Pasciak LaRiviere

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

US Food and Drug Administration

62 stories

Children

42 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.